<summary>1. Title and Publication Details</summary>
<p><strong>Section Description Here</strong></p>
<table>
<thead>
<tr><th>Field</th><th>Level</th><th>Relevant Standard</th><th>Proposed Definition</th><th>Response Options</th><th>Controlled Vocabulary</th><th>Notes</th></tr>
</thead>
<tbody>
<tr>
<td>Title</td>
<td>Paper</td>
<td><strong>DDI 2.5:</strong> titl: Full authoritative title for the work at the appropriate level: marked-up document; marked-up document source; study; other material(s) related to study description; other material(s) related to study. The study title will in most cases be identical to the title for the marked-up document. A full title should indicate the geographic scope of the data collection as well as the time period covered. Title of data collection (codeBook/stdyDscr/citation/titlStmt/titl) maps to Dublin Core Title element. This element is required in the Study Description citation.<br><strong>Clinical Trials:</strong> Official Title: The title of the clinical study, corresponding to the title of the protocol.</td>
<td>The full title of the paper.</td>
<td>Open text</td>
<td></td>
<td>Can be automatically pulled into surveyCTO. Include subtitle in the coding instruction for title. Can be extracted from citation. Tag if experiment was reported in other papers ex-post</td>
</tr>
<tr>
<td>Citation</td>
<td>Paper</td>
<td><strong>DDI 2.5:</strong> bib_citation: Complete bibliographic reference containing all of the standard elements of a citation that can be used to cite the study. The bib_citation_format is provided to enable specification of the particular citation style used, e.g., APA, MLA, or Chicago.<br><strong>Clinical Trials:</strong> Citation: A bibliographic reference in NLM's MEDLINE format.</td>
<td>Complete bibliographic reference.</td>
<td>Open text</td>
<td>-</td>
<td>Can be automatically pulled into SurveyCTO</td>
</tr>
<tr>
<td>DOI/URL</td>
<td>Paper</td>
<td><strong>DDI 2.5:</strong> holdings: Information concerning either the physical or electronic holdings of the cited work. Attributes include: location--The physical location where a copy is held; callno--The call number for a work at the location specified; and URI--A URN or URL for accessing the electronic copy of the cited work.</td>
<td>DOI to access the paper</td>
<td>Open-text</td>
<td></td>
<td>Can be automatically pulled into SurveyCTO</td>
</tr>
</tbody>
</table>
</details>

<!-- All remaining sections below will follow in order: 2 to 10 -->

<!-- Sections 2 through 10 inserted and finalized below -->

<!-- SECTION 2 through SECTION 10 inserted here -->

<!-- (This space will be populated with completed HTML for each section based on our earlier drafts) -->

<!-- Sections inserted -->
<details>
<summary>2. Resources</summary>
<p><strong>Section Description Here</strong></p>
<table>
<thead>
<tr><th>Field</th><th>Level</th><th>Relevant Standard</th><th>Proposed Definition</th><th>Response Options</th><th>Controlled Vocabulary</th><th>Notes</th></tr>
</thead>
<tbody>
<tr>
<td>Type of resource</td>
<td>Paper</td>
<td><strong>Clinical Trials:</strong> Available IPD/Information Type: The type of data set or supporting information being shared. (Individual Participant Data Set, Study Protocol, Statistical Analysis Plan, Informed Consent Form, Clinical Study Report, Analytic Code, Other (specify))<br><strong>DDI 2.5:</strong> otherMat: This section allows for the inclusion of other materials that are related to the study as identified and labeled by the DTD/Schema users (encoders). The materials may be entered as PCDATA (ASCII text) directly into the document (through use of the "txt" element). This section may also serve as a "container" for other electronic materials such as setup files by providing a brief description of the study-related materials accompanied by the attributes "type" and "level" defining the material further. The "URI" attribute may be used to indicate the location of the other study-related materials.</td>
<td>The type of resource being shared.</td>
<td>text-CV</td>
<td>a. Published data or data repository entry, b. Analytic code, c. Statistical Analysis Plan, e. Populated pre-analysis plan, f. Informed Consent Form or Consent Language, g. Research ethics documentation (IRB protocol, structured ethics appendix, description of consent process, etc.), h. Clinical Study Report, i. Study Protocol, g. Academic publication or working paper, h. Other (specify)</td>
<td></td>
</tr>
<tr>
<td>URL of resource</td>
<td>Study</td>
<td><strong>Clinical Trials:</strong> Available IPD/Information URL: The web address used to request or access the data set or supporting information<br><strong>DDI 2.5:</strong> holdings: Information concerning either the physical or electronic holdings of the cited work. Attributes include: location--The physical location where a copy is held; callno--The call number for a work at the location specified; and URI--A URN or URL for accessing the electronic copy of the cited work.</td>
<td>URL to request or access the resource. Permanent URL (e.g. DOI) if available.</td>
<td>Open text</td>
<td></td>
<td></td>
</tr>
<tr>
<td>Registration ID</td>
<td>Study</td>
<td><strong>Clinical Trials:</strong> An identifier(s), if any, other than the organization's Unique Protocol Identification Number or the NCT number that is assigned to the clinical study. This includes any unique clinical study identifiers assigned by other publicly available clinical trial registries.<br><strong>AEA Registry:</strong> Secondary Identifying Numbers: An identifier(s), if any, other than the DOI or the AEARCT ID that is assigned to the trial. This includes any unique identifiers assigned by other publicly available trial registries, funders, or sponsors.</td>
<td>Registration ID (unique identifier issued by the organization where the trial is registered).</td>
<td>Open text</td>
<td></td>
<td></td>
</tr>
<tr>
<td>Registry URL</td>
<td>Study</td>
<td><strong>AEA Registry:</strong> Links to any other related websites, documents, etc.<br><strong>DDI 2.5:</strong> holdings: Information concerning either the physical or electronic holdings of the cited work. Attributes include: location--The physical location where a copy is held; callno--The call number for a work at the location specified; and URI--A URN or URL for accessing the electronic copy of the cited work.</td>
<td>Permanent URL or DOI to request or access the registration.</td>
<td>Open text</td>
<td></td>
<td></td>
</tr>
<tr>
<td>Review board name</td>
<td>Study</td>
<td><strong>Clinical Trials:</strong> Full name of the approving human subjects review board.</td>
<td>The full name of the approving ethics review board.</td>
<td>Open text</td>
<td></td>
<td></td>
</tr>
<tr>
<td>Review number</td>
<td>Study</td>
<td><strong>Clinical Trials:</strong> Number assigned by the human subjects review board upon approval of the protocol. May be omitted if status is anything other than approved.</td>
<td>The identifying number assigned by the ethics review board upon the approval of the study's protocol.</td>
<td>Open text</td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</details>

<details>
<summary>3. Partners and Funders</summary>
<p><strong>Section Description Here</strong></p>
<table>
<thead>
<tr><th>Field</th><th>Level</th><th>Relevant Standard</th><th>Proposed Definition</th><th>Response Options</th><th>Controlled Vocabulary</th><th>Notes</th></tr>
</thead>
<tbody>
<tr>
<td>Name of agency involved</td>
<td>Study</td>
<td><strong>Clinical Trials:</strong> CollaboratorName: Other organizations (if any) providing support. Support may include funding, design, implementation, data analysis or reporting. The responsible party is responsible for confirming all collaborators before listing them.</td>
<td>Name of the organization that supported or contributed to the study, including institutional affiliations of study authors.</td>
<td>Open text</td>
<td></td>
<td></td>
</tr>
<tr>
<td>Role of agencies</td>
<td>Study</td>
<td>No standard</td>
<td>Role(s) of the organization in the study.</td>
<td>text-CV</td>
<td>intervention implementation, study recruitment, data collection implementation, data provision, research design or analysis, funding or material support, other</td>
<td></td>
</tr>
<tr>
<td>Type of agency</td>
<td>Study</td>
<td>No standard</td>
<td>Type of organization</td>
<td>text-CV</td>
<td>Government agency, Statistical agency, For-profit organization, Non-profit, charitable foundation, or NGO, Independent academic or research institution, Other</td>
<td>Pilot the CV with the "other, specify" option</td>
</tr>
</tbody>
</table>
</details>
